3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Hodgkin Disease
1
Carcinoma, Hepatocellular
1
Interventions
Peripheral Blood Stem Cell Transplantation
28
fludarabine phosphate
25
Cyclophosphamide
19
Cyclosporine
18
Whole-Body Irradiation
17
Mycophenolic Acid
17
Tacrolimus
15
Busulfan
13
Antilymphocyte Serum
11
Methotrexate
10
Methylprednisolone
8
Filgrastim
8
Vorinostat
7
Radiotherapy
7
Flow Cytometry
7
Etoposide
7
Bortezomib
6
Psychiatric Rehabilitation
5
Everolimus
5
Dexamethasone
5
Bexarotene
5
Alemtuzumab
5
Transplantation
4
Therapeutics
4
Polymerase Chain Reaction
4
Panobinostat
4
Lenalidomide
4
Gemcitabine
4
Carboplatin
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sezary Syndrome
×
resminostat
×
Clear all
NCT02953301
2024-08-30
RESMAIN
4SC AG
Phase 2
Completed
201 enrolled